TP53 and cancer: Chronic hypoxia induces genomic instability changes within cancer cells, and influences the expression level of the tumor suppressor gene (p53), vascular endothelial growth factor (VEGF), and angiogenin to inhibit programmed cell death and reduce cell cycle arrest, resulting in the emergence of cancer cell resistance towards different chemotherapies [46].